These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37884182)

  • 1. Butyrylcholinesterase signal sequence self-aggregates and enhances amyloid fibril formation in vitro.
    Jasiecki J; Targońska M; Janaszak-Jasiecka A; Kalinowski L; Waleron K; Wasąg B
    Chem Biol Interact; 2023 Dec; 386():110783. PubMed ID: 37884182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
    Macdonald IR; Maxwell SP; Reid GA; Cash MK; DeBay DR; Darvesh S
    J Alzheimers Dis; 2017; 58(2):491-505. PubMed ID: 28453492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Exogenous Butyrylcholinesterase with β-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain.
    Reid GA; Darvesh S
    Curr Alzheimer Res; 2021; 18(6):470-481. PubMed ID: 34455970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-β plaques in human brain tissue.
    Reid GA; Darvesh S
    Chem Biol Interact; 2024 May; 395():111012. PubMed ID: 38648920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Jasiecki J; Limon-Sztencel A; Żuk M; Chmara M; Cysewski D; Limon J; Wasąg B
    Sci Rep; 2019 Mar; 9(1):5223. PubMed ID: 30914707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
    Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
    Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.
    Reid GA; Darvesh S
    Neuroscience; 2015 Jul; 298():424-35. PubMed ID: 25931333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology and cholinesterase expression in the brains of octogenarians and older.
    Maxwell SP; Cash MK; Darvesh S
    Chem Biol Interact; 2022 Sep; 364():110065. PubMed ID: 35872043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrylcholinesterase attenuates amyloid fibril formation in vitro.
    Diamant S; Podoly E; Friedler A; Ligumsky H; Livnah O; Soreq H
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8628-33. PubMed ID: 16731619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation and structure of amyloid β-protein.
    Ono K; Watanabe-Nakayama T
    Neurochem Int; 2021 Dec; 151():105208. PubMed ID: 34655726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer's Disease Pathogenesis.
    Jasiecki J; Targońska M; Wasąg B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.
    Cisternas P; Zolezzi JM; Lindsay C; Rivera DS; Martinez A; Bozinovic F; Inestrosa NC
    J Alzheimers Dis; 2018; 66(3):1145-1163. PubMed ID: 30412496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid polypeptide fibril catalyzes amyloid-β aggregation by promoting fibril nucleation rather than direct axial growth.
    Song Z; Tang H; Gatch A; Sun Y; Ding F
    Int J Biol Macromol; 2024 Nov; 279(Pt 1):135137. PubMed ID: 39208885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
    Hamodat H; Cash MK; Fisk JD; Darvesh S
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.
    Kang CK; Jayasinha V; Martin PT
    Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of insoluble Amyloid-β with soluble Amyloid-β dimers decreases Amyloid-β plaque numbers.
    van Gerresheim EF; Herring A; Gremer L; Müller-Schiffmann A; Keyvani K; Korth C
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):603-610. PubMed ID: 33338256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could
    Jasiecki J; Wasąg B
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31601022
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential Binding and Conformational Dynamics of Tau Microtubule-Binding Repeats with a Preformed Amyloid-β Fibril Seed.
    Song Z; Gatch AJ; Sun Y; Ding F
    ACS Chem Neurosci; 2023 Apr; 14(7):1321-1330. PubMed ID: 36975100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.